Chuck Padala | Managing Director, LifeSci Advisors |
Adi Mohanty | Chief Executive Officer |
Eric d'Esparbes | Chief Financial Officer |
Joe Pantginis | H.C. Wainwright |
Julian Harrison | BTIG |
John Vandermosten | Zacks Investment Research |
Greetings, and welcome to the Biora Therapeutics Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It's now my pleasure to introduce your host, Chuck Padala, Managing Director with LifeSci Advisors.